KLOW is a co-lyophilized four-component peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV in a fixed ratio, commonly referenced in laboratory research for simultaneous investigation of ECM remodeling, angiogenic signaling, cytoskeletal dynamics, and NF-B inflammatory pathway modulation
The advisory committee narrowly recommended listing both forms, but FDA's scientific reviewers recommended against it
It should not be confused with Melanotan I (afamelanotide), which is a related but distinct compound with a narrower receptor activity profile
This isn't a reason to avoid compounded injectable GLP-1s - it's a reason to make sure your provider explains exactly how to measure and administer your specific dose before your first injection, and to confirm that the compounding pharmacy provides appropriate syringe sizing for your prescribed dose
& Subra, G
If you are building a fuller daily stack, our supplement quiz can help point you in the right direction